Cationic polyene phospholipids as DNA carriers for ocular gene therapy
Recent success in the treatment of congenital blindness demonstrates the potential of ocular gene therapy as a therapeutic approach. The eye is a good target due to its small size, minimal diffusion of therapeutic agent to the systemic circulation, and low immune and inflammatory responses. Currentl...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2017
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.1/9874 |
País: | Portugal |
Oai: | oai:sapientia.ualg.pt:10400.1/9874 |